Highly efficient RNP delivery
for In vivo therapeutic
applications
We have developed a nanocarrier technology to effectively
deliver Cas9/gRNA complex (RNP) to target cells.
This platform technology can be applied to gene therapies for
various incurable diseases including metastatic tumours and genetic diseases.
